You are here

 - MRI

BOSTON—Patients with the Iforia ProMRI implantable cardiac device (ICD) system had no adverse outcomes related to the device and no significant changes to pacing or sensing parameters after undergoing a thoracic spine or cardiac MRI, according to a multicenter, nonrandomized trial.

 - patient

BOSTON—Patients with heart failure who failed standard, optimal cardiac resynchronization therapy (CRT) approaches had significant improvements in clinical outcomes after receiving a novel device that provided endocardial left ventricular stimulation.

 - Canada flag, Canadian

BOSTON—After a mean follow-up of 7.5 years, electrical failure occurred in 5.9 percent of patients using the Riata lead, according to a prospective, observational study of the Riata leads under advisory in Canada. In addition, 7.4 percent of patients had electrical failure or cable externalization.

 - Patient

BOSTON—A novel approach known as baroreflex activation therapy led to a 30 percent improvement in New York Heart Association  classification and an increase in quality of life among patients with heart failure and reduced ejection fraction who had failed previous therapies.

 - brain, stroke

BOSTON—Patients with atrial fibrillation underestimated the risk of stroke but wanted to work with their physicians and caregivers to better manage their disease, according to a survey released on May 13 from the Heart Rhythm Society and the National Stroke Association.